Results of Pilot Study That Monitored Patients with Functional Dyspepsia, Gastroparesis and Vomiting Presented at Digestive Disease Week 2023
10 mai 2023 09h00 HE
|
G-Tech Medical
MOUNTAIN VIEW, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- G-Tech Medical today announced an oral presentation of an abstract entitled A Novel, Non-invasive, 6-day Wireless Motility Patch System...
Interim Results of Study That Used Non-invasive Wireless Patches to Monitor Myoelectric Activity of Crohn’s Disease Patients in Flare and Remission
09 mai 2023 09h00 HE
|
G-Tech Medical
MOUNTAIN VIEW, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced presentation of...
USD 44 Bn Medical Foods Market to Grow at a CAGR of 7.5% During 2023 to 2031 | Transparency Market Research
29 mars 2023 15h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, March 30, 2023 (GLOBE NEWSWIRE) -- According to market research conducted by TMR, the global medical foods industry was valued at USD 23.0 Bn in 2022 and is...
G-Tech Medical Receives FDA Clearance for its Gastrointestinal Motility Monitoring System
13 janv. 2022 09h00 HE
|
G-Tech Medical
MOUNTAIN VIEW, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced U.S. Food and...
AzurRx BioPharma Provides Insight into Drawbacks of Using Porcine Products in Production of Pharmaceuticals and Medicinals, Offers Update on Efforts to Produce Synthetic Alternatives
29 oct. 2020 12h05 HE
|
AzurRx BioPharma, Inc.
NEW YORK, Oct. 29, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- AzurRx BioPharma, Inc. (NASDAQ: AZRX) (“AzurRx” or the “Company”), a New York-based biopharmaceutical company specializing in the...
PEGylated Drugs Market in Europe and North America worth over $10.5 billion by 2024: Global Market Insights, Inc.
17 avr. 2018 04h00 HE
|
Global Market Insights, Inc
Sellbyville, Delaware, April 17, 2018 (GLOBE NEWSWIRE) -- North America and Europe PEGylated Drugs Market is expected to surpass USD 10.5 billion by 2024; according to a new research report by...